Munafa Stock Market Course + Intraday & FNO calls 
EDIT NEWS why is Editas Medicine, Inc. price falling or rising
EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising
EDIT Editas Medicine is falling or rising technical reasons
Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.
It appears as if Editas Medicine EDIT gave a large move recently.
Stock of Editas Medicine (EDIT) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...
EDIT Editas Medicine is falling or rising NEWS fundamental reasons
Higher crude prices fuel bank lending boom; credit growth hits 17.7%, fastest since June 2024 Bank lending saw its fastest growth in almost two years by May 31, 2026. Credit expanded significantly, reaching Rs 215.2 lakh crore. This surge occurred as bank deposits decreased by Rs 2.3 lakh crore. The gap between loans and deposits widened. Oil marke - NEWS as on 2026-06-12 indiatimes.com
Govt eyes rural credit push via flagship schemes, seeks to expand RRB customer base The government is enhancing rural credit by integrating the Grameen Credit Score with the JanSamarth portal for faster loan processing. Regional Rural Banks will expand their customer base and diversify into investment credit, while also promoting digital - NEWS as on 2026-06-11 indiatimes.com
Private Credit Keeps Making Headlines. Is Ares Capital's Big Dividend Still Safe? Key PointsAres Capital is a large business development company that invests in the same types of assets as private credit businesses. - NEWS as on 2026-06-10 nasdaq.com
US Stock Market: Private credit funds face fresh redemption test as investor withdrawals remain elevated Private credit funds catering to wealthy investors are coming under renewed pressure as redemption requests remain elevated in the second quarter. Early filings reviewed by Reuters indicate that concerns over software-sector exposure, asset valuations, and - NEWS as on 2026-06-05 indiatimes.com
Blackstone private credit fund caps withdrawals as redemption requests surge After investors sought to pull out 10% of shares in the second-quarter tender offer, compared to 7.9% in the previous quarter, the billion Blackstone Private Credit Fund limited withdrawals to 5%, the customary limit for these vehicles. - NEWS as on 2026-06-04 indiatimes.com
ETMarkets AIF Talk| Returns with liquidity: How Vivriti's semi-liquid debt fund is redefining private credit investing, says Priyam Kedia Vivriti's Short Term Debt Fund offers private credit-like returns with periodic liquidity, resonating with investors. India's private credit market has matured, with domestic capital playing a dominant role. Vivriti emphasizes portfolio monitoring, AI inte - NEWS as on 2026-06-03 indiatimes.com
RBI reviews expected credit loss rules amid concerns over impact on SME credit costs The Reserve Bank of India is taking a closer look at its credit loss regulations, which may result in higher borrowing costs for small and mid-sized firms. With rating agencies recently exceeding default rate benchmarks, there is a chance of elevated risk - NEWS as on 2026-06-02 indiatimes.com
Vedanta secures highest credit rating in over decade following ICRA Upgrade Vedanta Group achieved its highest domestic credit rating in over a decade. ICRA upgraded key group entities, Vedanta Ltd and Vedanta Aluminium Metal Ltd, to AA+ with a stable outlook. This upgrade reflects strong operational performance and a robust finan - NEWS as on 2026-05-29 indiatimes.com
Karur Vysya Bank bets big on credit cards, microloans and corporate push to double down on growth Karur Vysya Bank is set for significant growth. The bank plans to expand its balance sheet by entering the credit card business and offering loans against mutual funds. A renewed focus on microloans and increasing corporate lending are also key strategies. - NEWS as on 2026-05-28 indiatimes.com
More announcements and NEWS
EDIT Editas Medicine, Inc. current price & indicator signals
Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 12 Fri Jun 2026 | 2.50 | 2.43 to 2.60 | 2.88% | 0.77 times |
| 11 Thu Jun 2026 | 2.43 | 2.38 to 2.60 | -2.02% | 0.75 times |
| 10 Wed Jun 2026 | 2.48 | 2.46 to 2.68 | -6.77% | 0.59 times |
| 09 Tue Jun 2026 | 2.66 | 2.49 to 2.74 | 0.38% | 0.63 times |
| 08 Mon Jun 2026 | 2.65 | 2.61 to 2.81 | -2.21% | 0.54 times |
| 05 Fri Jun 2026 | 2.71 | 2.63 to 3.00 | -9.36% | 0.91 times |
| 04 Thu Jun 2026 | 2.99 | 2.77 to 3.13 | 7.55% | 1.01 times |
| 03 Wed Jun 2026 | 2.78 | 2.63 to 2.91 | -1.42% | 1.29 times |
| 02 Tue Jun 2026 | 2.82 | 2.81 to 3.43 | -15.57% | 1.46 times |
| 01 Mon Jun 2026 | 3.34 | 3.29 to 3.51 | -3.47% | 1.25 times |
| 29 Fri May 2026 | 3.46 | 3.24 to 3.50 | 0.87% | 1.57 times |
| 28 Thu May 2026 | 3.43 | 3.36 to 3.58 | -3.38% | 1.99 times |
Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
